These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6690131)

  • 1. Buflomedil concentrations in blood and viscera in a case of fatal intoxication.
    Athanaselis S; Maravelias C; Michalodimitrakis M; Koutselinis A
    Clin Chem; 1984 Jan; 30(1):157. PubMed ID: 6690131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suicidal buflomedil intoxication].
    Babel B; Tatschner T; Patzelt D
    Arch Kriminol; 2004; 213(3-4):108-13. PubMed ID: 15137632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Papa P; Rocchi L; Mainardi C; Donzelli G
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation and ultraviolet spectrum identification of buflomedil in whole blood and plasma by HPLC.
    Rop PP; Bresson M; Antoine J; Spinazzola J; Fornaris M; Viala A
    J Anal Toxicol; 1990; 14(1):18-21. PubMed ID: 2314057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe intoxications by buflomedil. 2 cases].
    Goulle JP; Droy JM; Moritz F; Lacroix C; Charbonneau P; Bonmarchand G; Leroy J
    Presse Med; 1995 Jun; 24(22):1048. PubMed ID: 7667237
    [No Abstract]   [Full Text] [Related]  

  • 7. Suicide by buflomedil HCl: a case report.
    Neri C; Barbareschi M; Turrina S; De Leo D
    J Clin Forensic Med; 2004 Feb; 11(1):15-6. PubMed ID: 15261008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical pharmacokinetics of buflomedil].
    Gundert-Remy U
    Med Welt; 1983 Sep; 34(35):923-5. PubMed ID: 6633218
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute toxicity of (2,4,6-trimethoxy) phenyl-3 (pyrrolidinyl-1) propyl-ketone chlorhydrate (buflomedil) and of metacrylic copolymers (eudragit) both alone and in association in the mouse and rat].
    Piccinelli D; de Feo G
    Boll Soc Ital Biol Sper; 1985 Dec; 61(11-12):1579-85. PubMed ID: 3833274
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid HPLC measurement of buflomedil in plasma in poisoning cases.
    Forfar-Bares I; Pehourcq F; Jarry C
    Biomed Chromatogr; 2002 Oct; 16(7):482-5. PubMed ID: 12378562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic method for the measurement of buflomedil in plasma and serum.
    Eastwood RJ; Bhamra RK; Holt DW
    J Chromatogr; 1990 Oct; 532(1):187-92. PubMed ID: 2079534
    [No Abstract]   [Full Text] [Related]  

  • 12. Buflomedil: three month intravenous safety evaluation in rats.
    Fort FL; Tekeli S; Lewkowski JP; Heyman IA; Cusick PK; Kesterson JW
    Drug Chem Toxicol; 1982; 5(4):401-14. PubMed ID: 7169013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a high performance liquid chromatography-tandem mass spectrometry method for determination of buflomedil in human plasma for a bioequivalence study.
    Ren L; Yang C; Peng Y; Li F; Li YH; Zheng H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 935():41-6. PubMed ID: 23939201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination half-life of alpha-pyrrolidinovalerophenone in an acute non-fatal intoxication.
    Quesada L; Gomila I; Yates C; Barcelo C; Puiguriguer J; Barcelo B
    Clin Toxicol (Phila); 2016 Jul; 54(6):531-2. PubMed ID: 27035402
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of buflomedil in mouse, rat and rabbit plasma by reversed-phase ion-pair high-performance liquid chromatography.
    Thomas EW
    J Chromatogr; 1982 Mar; 228():387-91. PubMed ID: 7076767
    [No Abstract]   [Full Text] [Related]  

  • 16. Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants.
    Mura P; Kintz P; Robert R; Papet Y
    J Anal Toxicol; 1998; 22(3):254. PubMed ID: 9602946
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011.
    Bucolo C; Longo L; Camillieri G; Drago F; Salomone S
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1190-6. PubMed ID: 22855302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study.
    Bourguignon L; Ducher M; Matanza D; Bleyzac N; Uhart M; Odouard E; Maire P; Goutelle S
    Fundam Clin Pharmacol; 2012 Apr; 26(2):279-85. PubMed ID: 22004557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
    Beck O; Franzén L; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbial transformation of buflomedil by Cunninghamella blakesleana AS 3.153].
    Wang W; Yang YN; Ma XM; Bu P; Sun L
    Yao Xue Xue Bao; 2012 Jul; 47(7):934-40. PubMed ID: 22993861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.